These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29557239)

  • 21. Differentiation between benign and malignant breast lesions using quantitative diffusion-weighted sequence on 3 T MRI.
    Tan SL; Rahmat K; Rozalli FI; Mohd-Shah MN; Aziz YF; Yip CH; Vijayananthan A; Ng KH
    Clin Radiol; 2014 Jan; 69(1):63-71. PubMed ID: 24156797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative non-Gaussian diffusion and intravoxel incoherent motion magnetic resonance imaging: differentiation of malignant and benign breast lesions.
    Iima M; Yano K; Kataoka M; Umehana M; Murata K; Kanao S; Togashi K; Le Bihan D
    Invest Radiol; 2015 Apr; 50(4):205-11. PubMed ID: 25260092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T2-hypointense rim of breast mass lesions on magnetic resonance images: Radiologic-pathologic correlation.
    Nakashima K; Uematsu T; Sugino T; Takahashi K; Nishimura S; Tadokoro Y; Hayashi T
    Breast J; 2018 Nov; 24(6):944-950. PubMed ID: 29785726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of diffusion kurtosis imaging in characterization of breast lesions.
    Christou A; Ghiatas A; Priovolos D; Veliou K; Bougias H
    Br J Radiol; 2017 May; 90(1073):20160873. PubMed ID: 28383279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The hyperechoic zone around breast lesions - an indirect parameter of malignancy.
    Durmus T; Stöckel J; Slowinski T; Thomas A; Fischer T
    Ultraschall Med; 2014 Dec; 35(6):547-53. PubMed ID: 25474101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of 3D and 2D shear-wave elastography for differentiating benign and malignant breast masses: focus on the diagnostic performance.
    Choi HY; Sohn YM; Seo M
    Clin Radiol; 2017 Oct; 72(10):878-886. PubMed ID: 28526455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison between breast MRI and contrast-enhanced spectral mammography.
    Łuczyńska E; Heinze-Paluchowska S; Hendrick E; Dyczek S; Ryś J; Herman K; Blecharz P; Jakubowicz J
    Med Sci Monit; 2015 May; 21():1358-67. PubMed ID: 25963880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of the ADC ratio in the differential diagnosis of breast lesions.
    Zhao J; Guan H; Li M; Gu H; Qin J; Wu X
    Acta Radiol; 2016 Apr; 57(4):422-9. PubMed ID: 26071495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of DW/DCE-MRI features with prognostic factors in breast cancer.
    Shao G; Fan L; Zhang J; Dai G; Xie T
    Int J Biol Markers; 2017 Mar; 32(1):e118-e125. PubMed ID: 27646773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic resonance imaging: value of diffusion-weighted imaging in differentiating benign from malignant breast lesions.
    Stijven S; Gielen E; Bevernage C; Horvath M; Meylaerts L
    Eur J Obstet Gynecol Reprod Biol; 2013 Feb; 166(2):215-20. PubMed ID: 23219320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential MRI interpretation model: differentiation of benign from malignant breast masses.
    Malich A; Fischer DR; Wurdinger S; Boettcher J; Marx C; Facius M; Kaiser WA
    AJR Am J Roentgenol; 2005 Oct; 185(4):964-70. PubMed ID: 16177416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eight echo T2 measurements of adrenal masses: limitations of differential diagnosis by relaxation time determination.
    Gruss LP; Newhouse JH
    J Comput Assist Tomogr; 1996; 20(5):792-7. PubMed ID: 8797915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic accuracy of (18)F-FDG PET/CT compared with that of contrast-enhanced MRI of the breast at 3 T.
    Magometschnigg HF; Baltzer PA; Fueger B; Helbich TH; Karanikas G; Dubsky P; Rudas M; Weber M; Pinker K
    Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1656-1665. PubMed ID: 26121928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of spatiotemporal changes for the classification of dynamic contrast-enhanced magnetic-resonance breast lesions.
    Milenković J; Hertl K; Košir A; Zibert J; Tasič JF
    Artif Intell Med; 2013 Jun; 58(2):101-14. PubMed ID: 23548472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging.
    Ricci P; Cantisani V; Ballesio L; Pagliara E; Sallusti E; Drudi FM; Trippa F; Calascibetta F; Erturk SM; Modesti M; Passariello R
    Ultraschall Med; 2007 Feb; 28(1):57-62. PubMed ID: 17304413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast Nonmass Enhancement Detected with MRI: Uility and Lesion Characterization with Second-Look Ultrasonography.
    Hsu HH; Chang TH; Chou YC; Peng YJ; Ko KH; Chang WC; Lin YP; Hsu GC; Yu JC
    Breast J; 2015; 21(6):579-87. PubMed ID: 26390913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size.
    Partridge SC; Mullins CD; Kurland BF; Allain MD; DeMartini WB; Eby PR; Lehman CD
    AJR Am J Roentgenol; 2010 Jun; 194(6):1664-73. PubMed ID: 20489111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
    Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
    Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic malignant tumour versus cavernous haemangioma: differentiation on multiple breath-hold turbo spin-echo MRI sequences with different T2-weighting and T2-relaxation time measurements on a single slice multi-echo sequence.
    Chan YL; Lee SF; Yu SC; Lai P; Ching AS
    Clin Radiol; 2002 Apr; 57(4):250-7. PubMed ID: 12014868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance imaging reveals functional diversity of the vasculature in benign and malignant breast lesions.
    Furman-Haran E; Schechtman E; Kelcz F; Kirshenbaum K; Degani H
    Cancer; 2005 Aug; 104(4):708-18. PubMed ID: 15971199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.